Follicular proliferation TIR3B: the role of total thyroidectomy vs lobectomy.
Follicular proliferation
Lobectomy
Malignancy
Surgery
TIR3B
Thyroid cancer
Total thyroidectomy
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
24 Apr 2019
24 Apr 2019
Historique:
received:
16
11
2018
accepted:
08
02
2019
entrez:
11
5
2019
pubmed:
11
5
2019
medline:
3
7
2019
Statut:
epublish
Résumé
TIR3B thyroid nodules are considered to be at risk of malignancy (15-30%) but guidelines recommend conservative surgery with lobectomy with primary diagnostic porpoise. Risk stratification mainly based on ultrasound, elastography and genetic mutations usually may influences the surgical approach. We retrospectively analyzed 52 cases of TIR3B underwent between 2015 and 2017 total thyroidectomy (TT) and lobectomy (L), focusing mainly on the observed rate of malignancy. Chi-squared test and Fisher's exact probability test were used for analysis, considering a P values less than 0.05 as significant. Out of 52 patients 49 underwent TT and 3 L. In TT group a multinodular goiter was associated in 67.3% of patients. Malignancy rate was 81.6 and 33.3% respectively after TT and L (P 0.003). Multicentric and contralateral tumors were detected respectively in 36.7% and in 32.6% of patients underwent TT. No main post-operative complications were registered. Ultrasound and elastography are useful to define within the TIR3B group those lesions at higher risk and therefore requiring a more radical approach. TT seems an appropriate approach to TIR3B lesions, especially in multinodular goiter, considering the incidence of malignancy with probably higher rate than previously reported.
Sections du résumé
BACKGROUND
BACKGROUND
TIR3B thyroid nodules are considered to be at risk of malignancy (15-30%) but guidelines recommend conservative surgery with lobectomy with primary diagnostic porpoise. Risk stratification mainly based on ultrasound, elastography and genetic mutations usually may influences the surgical approach.
METHODS
METHODS
We retrospectively analyzed 52 cases of TIR3B underwent between 2015 and 2017 total thyroidectomy (TT) and lobectomy (L), focusing mainly on the observed rate of malignancy. Chi-squared test and Fisher's exact probability test were used for analysis, considering a P values less than 0.05 as significant.
RESULTS
RESULTS
Out of 52 patients 49 underwent TT and 3 L. In TT group a multinodular goiter was associated in 67.3% of patients. Malignancy rate was 81.6 and 33.3% respectively after TT and L (P 0.003). Multicentric and contralateral tumors were detected respectively in 36.7% and in 32.6% of patients underwent TT. No main post-operative complications were registered.
CONCLUSIONS
CONCLUSIONS
Ultrasound and elastography are useful to define within the TIR3B group those lesions at higher risk and therefore requiring a more radical approach. TT seems an appropriate approach to TIR3B lesions, especially in multinodular goiter, considering the incidence of malignancy with probably higher rate than previously reported.
Identifiants
pubmed: 31074384
doi: 10.1186/s12893-019-0485-9
pii: 10.1186/s12893-019-0485-9
pmc: PMC7402575
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
22Références
J Otolaryngol Head Neck Surg. 2016 Feb 27;45:16
pubmed: 26921257
Head Neck. 2013 Oct;35(10):1499-506
pubmed: 22972563
Cancer Cytopathol. 2015 Dec;123(12):713-22
pubmed: 26355876
Surgery. 2017 Jan;161(1):168-175
pubmed: 27863786
Endocr Pract. 2017 Apr 2;23(4):442-450
pubmed: 28095042
Tumori. 2013 May-Jun;99(3):342-50
pubmed: 24158063
Cytopathology. 2016 Apr;27(2):115-21
pubmed: 25810099
Acta Cytol. 2012;56(4):333-9
pubmed: 22846422
J Surg Res. 2017 Oct;218:237-245
pubmed: 28985856
Int J Endocrinol. 2017;2017:9692304
pubmed: 28348589
Updates Surg. 2017 Jun;69(2):145-150
pubmed: 28405952
Endocrine. 2017 Feb;55(2):530-538
pubmed: 27075721
Thyroid. 2014 May;24(5):832-9
pubmed: 24341462
Surgery. 2018 Jan;163(1):75-80
pubmed: 29122328
Cancer Cytopathol. 2011 Oct 25;119(5):315-21
pubmed: 21751427
Medicine (Baltimore). 2017 Oct;96(43):e8282
pubmed: 29068996
J Endocrinol Invest. 2014 Jun;37(6):593-9
pubmed: 24789536
J Surg Res. 2013 Sep;184(1):189-92
pubmed: 23777982
Int J Surg. 2014;12 Suppl 1:S29-34
pubmed: 24859409
J Ultrasound Med. 2018 Apr;37(4):1007-1014
pubmed: 29044641
J Am Coll Surg. 2017 Jun;224(6):1021-1027
pubmed: 28017809
N Engl J Med. 2013 Jan 3;368(1):6-8
pubmed: 23281971
Ann Surg. 2014 Jul;260(1):163-8
pubmed: 24901361
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
J Biol Regul Homeost Agents. 2016 Oct-Dec;30(4):1187-1193
pubmed: 28078873
Int J Surg. 2016 Apr;28 Suppl 1:S75-8
pubmed: 26708856
Surgery. 2018 Jan;163(1):81-87
pubmed: 29128185